Pages that link to "Q28206065"

The following pages link to The genomic structure and expression of MJD, the Machado-Joseph disease gene (Q28206065):

Displaying 25 items.

• Machado-Joseph Disease: from first descriptions to new perspectives (Q21202868) (← links)
• Polarised asymmetric inheritance of accumulated protein damage in higher eukaryotes (Q27334980) (← links)
• (Q28162291) (redirect page) (← links)
• SCA3: neurological features, pathogenesis and animal models (Q31152886) (← links)
• Splice Isoforms of the Polyglutamine Disease Protein Ataxin-3 Exhibit Similar Enzymatic yet Different Aggregation Properties (Q33742179) (← links)
• Genomic structure, promoter activity, and developmental expression of the mouse homologue of the Machado-Joseph disease (MJD) gene (Q33948914) (← links)
• Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates (Q35171105) (← links)
• Patterned Purkinje cell death in the cerebellum (Q35563957) (← links)
• Toward understanding Machado-Joseph disease (Q35837355) (← links)
• A mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado-Joseph disease-like transgenic mice (Q36088535) (← links)
• Mouse models of Machado-Joseph disease and other polyglutamine spinocerebellar ataxias (Q36358879) (← links)
• Ataxin-3 phosphorylation decreases neuronal defects in spinocerebellar ataxia type 3 models (Q36583286) (← links)
• Machado–Joseph disease/spinocerebellar ataxia type 3 (Q36599588) (← links)
• Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease (Q37254846) (← links)
• Compromised mitochondrial complex II in models of Machado-Joseph disease. (Q39450953) (← links)
• A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration. (Q40493431) (← links)
• The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls. (Q41736716) (← links)
• Analysis of segregation patterns in Machado-Joseph disease pedigrees. (Q43800477) (← links)
• Increased transcript diversity: novel splicing variants of Machado-Joseph disease gene (ATXN3). (Q46303860) (← links)
• Segregation distortion of wild-type alleles at the Machado-Joseph disease locus: a study in normal families from the Azores islands (Portugal). (Q52804580) (← links)
• Sequence Analysis of 5′ Regulatory Regions of the Machado–Joseph Disease Gene (ATXN3) (Q57949688) (← links)
• Physiological and pathophysiological characteristics of ataxin-3 isoforms (Q64042586) (← links)
• The human MJD gene: genomic structure and functional characterization of the promoter region (Q79120845) (← links)
• Ataxin2 functions via CrebA to mediate Huntingtin toxicity in circadian clock neurons (Q90589829) (← links)
• Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease (Q91900969) (← links)